Probing the impact of chromatin conformation on genome editing tools

Nucleic Acids Research

Volumn 44, Issue 13, 2016, Pages 6482-6492

  Chen, Xiaoyu ^a   Rinsma, Marrit ^a   Janssen, Josephine M ^a   Liu, Jin ^a   Maggio, Ignazio ^a   Gonçalves, Manuel A F V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAS9 PROTEIN; RIBONUCLEOPROTEIN; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; CHROMATIN;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA CLEAVAGE; DNA SEQUENCE; EPIGENETICS; EUCHROMATIN; GENOME EDITING; HETEROCHROMATIN; HUMAN; HUMAN CELL; MOLECULAR GENETICS; PRIORITY JOURNAL; CHROMATIN; CONFORMATION; GENE EDITING; GENETIC ENGINEERING; GENETIC EPIGENESIS; GENETICS; GENOTYPE; STREPTOCOCCUS PYOGENES;

CHROMATIN; CRISPR-CAS SYSTEMS; EPIGENESIS, GENETIC; GENE EDITING; GENETIC ENGINEERING; GENOTYPE; HUMANS; MOLECULAR CONFORMATION; STREPTOCOCCUS PYOGENES; TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES;

EID: 84982854588     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw524     Document Type: Article

References (36)

1. Kim, H. and Kim, J.-S. (2014) A guide to genome engineering with programmable nucleases. Nat. Rev. Genet., 15, 321-334.
2. Maggio, I. and Gonçalves, M.A.F.V. (2015) Genome editing at the crossroads of delivery, specificity, and fidelity. Trends. Biotechnol., 33, 280-291.
3. Chylinski, K., Makarova, K.S., Charpentier, E. and Koonin, E.V. (2014) Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res., 42, 6091-6105.
4. Anders, C., Niewoehner, O., Duerst, A. and Jinek, M. (2014) Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature, 513, 569-573.
5. Chen, S., Oikonomou, G., Chiu, C.N., Niles, B.J., Liu, J., Lee, D.A., Antoshechkin, I. and Prober, D.A. (2013) A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly. Nucleic Acids Res., 41, 2769-2778.
6. Valton, J., Dupuy, A., Daboussi, F., Thomas, S., Maréchal, A., Macmaster, R., Melliand, K., Juillerat, A. and Duchateau, P. (2012) Overcoming Transcription Activator-like Effector (TALE) DNA binding domain sensitivity to cytosine methylation. J. Biol. Chem., 287, 38427-38432.
7. Wu, X., Kriz, A.J. and Sharp, P.A. (2014) Target specificity of the CRISPR-Cas9 system. Quant. Biol., 2, 59-70.
8. Kuscu, C., Arslan, S., Singh, R., Thorpe, J. and Adli, M. (2014) Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol., 32, 677-683.
9. O'Geen, H., Henry, I.M., Bhakta, M.S., Meckler, J.F. and Segal, D.J. (2015) A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res., 43, 3389-3404.
10. Polstein, L.R., Perez-Pinera, P., Kocak, D.D., Vockley, C.M., Bledsoe, P., Song, L., Safi, A., Crawford, G.E., Reddy, T.E. and Gersbach, C.A. (2015) Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE-and CRISPR/Cas9-based transcriptional activators. Genome Res., 25, 1158-1169.
11. Wu, X., Scott, D.A., Kriz, A.J., Chiu, A.C., Hsu, P.D., Dadon, D.B., Cheng, A.W., Trevino, A.E., Konermann, S., Chen, S. et al. (2014) Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol., 32, 670-676.
12. Certo, M.T., Ryu, B.Y., Annis, J.E., Garibov, M., Jarjour, J., Rawlings, D.J. and Scharenberg, A.M. (2011) Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods, 8, 671-676.
13. Szulc, J., Wiznerowicz, M., Sauvain, M.-O., Trono, D. and Aebischer, P. (2006) A versatile tool for conditional gene expression and knockdown. Nat. Methods, 3, 109-116.
14. Reyon, D., Tsai, S.Q., Khayter, C., Foden, J.A., Sander, J.D. and Joung, J.K. (2012) FLASH assembly of TALENs for high-throughput genome editing. Nat. Biotechnol., 30, 460-465.
15. Holkers, M., Maggio, I., Henriques, S.F., Janssen, J.M., Cathomen, T. and Gonçalves, M.A. (2014) Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat. Methods, 11, 1051-1057.
16. Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E. and Church, G.M. (2013) RNA-Guided Human Genome Engineering via Cas9. Science, 339, 823-826.
17. Kearns, N.A., Genga, R.M.J., Enuameh, M.S., Garber, M., Wolfe, S.A. and Maehr, R. (2013) Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development, 141, 219-223.
18. Chapdelaine, P., Moisset, P.-A., Campeau, P., Asselin, I., Vilquin, J.-T. and Tremblay, J.P. (2000) Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng., 13, 611-615.
19. Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng, Z. and Joung, J.K. (2016) High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 529, 490-495.
20. Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M. and Joung, J.K. (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol., 32, 279-284.
21. Slaymaker, I.M., Gao, L., Zetsche, B., Scott, D.A., Yan, W.X. and Zhang, F. (2016) Rationally engineered Cas9 nucleases with improved specificity. Science, 351, 84-88.
22. Maggio, I., Stefanucci, L., Janssen, J.M., Liu, J., Chen, X., Mouly, V. and Goncalves, M.A. (2016) Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Res., 44, 1449-1470.
23. Pelascini, L.P. and Goncalves, M.A. (2014) Lentiviral vectors encoding zinc-finger nucleases specific for the model target locus HPRT1. Methods. Mol. Biol., 1114, 181-199.
24. Pelascini, L.P., Janssen, J.M. and Goncalves, M.A. (2013) Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells. Hum. Gene Ther., 24, 78-96.
25. Brielmeier, M., Béchet, J.M., Falk, M.H., Pawlita, M., Polack, A. and Bornkamm, G.W. (1998) Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res., 26, 2082-2085.
26. Fallaux, F.J., Bout, A., van der Velde, I., van den Wollenberg, D.J., Hehir, K.M., Keegan, J., Auger, C., Cramer, S.J., van Ormondt, H., van der Eb, A.J. et al. (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther., 9, 1909-1917.
27. Lechner, M.S., Begg, G.E., Speicher, D.W. and Rauscher, F.J. (2000) Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential. Mol. Cell. Biol., 20, 6449-6465.
28. Nielsen, A.L., Ortiz, J.A., You, J., Oulad-Abdelghani, M., Khechumian, R., Gansmuller, A., Chambon, P. and Losson, R. (1999) Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. EMBO J., 18, 6385-6395.
29. Ayyanathan, K., Lechner, M.S., Bell, P., Maul, G.G., Schultz, D.C., Yamada, Y., Tanaka, K., Torigoe, K. and Rauscher, F.J. (2003) Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev., 17, 1855-1869.
30. Groner, A.C., Meylan, S., Ciuffi, A., Zangger, N., Ambrosini, G., Denervaud, N., Bucher, P. and Trono, D. (2010) KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet., 6, e1000869.
31. Becker, J.S., Nicetto, D. and Zaret, K.S. (2016) H3K9me3-Dependent Heterochromatin: Barrier to cell fate changes. Trends Genet., 32, 29-41.
32. Mahfouz, M.M., Li, L., Shamimuzzaman, M., Wibowo, A., Fang, X. and Zhu, J.K. (2011) De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc. Natl. Acad. Sci. U.S.A., 108, 2623-2628.
33. Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, D.E., Leung, E., Hinkley, S.J. et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat. Biotech., 29, 143-148.
34. Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F. and Nureki, O. (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 156, 935-949.
35. Horlbeck, M.A., Witkowsky, L.B., Guglielmi, B., Replogle, J.M., Gilbert, L.A., Villalta, J.E., Torigoe, S.E., Tjian, R. and Weissman, J.S. (2016) Nucleosomes impede Cas9 access to DNA in vivo and in vitro. ELife, 5, e12677.
36. Yang, L., Guell, M., Byrne, S., Yang, J.L., De Los Angeles, A., Mali, P., Aach, J., Kim-Kiselak, C., Briggs, A.W., Rios, X. et al. (2013) Optimization of scarless human stem cell genome editing. Nucleic Acids Res., 41, 9049-9061.